Sponsor pipeline

Valneva Austria GmbH clinical trial pipeline

Get alerts when Valneva Austria GmbH's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
1
Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04838444 Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) Chikungunya Virus Infection Active, Not Recruiting 2026-07-09
Not specified
NCT07254702 Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for… Chikungunya Virus Infection Active, Not Recruiting 2026-07-21
NCT07414524 VLA1553-403 Pregnancy Surveillance Study Chikungunya Virus Infection Enrolling by Invitation 2026-07-20
NCT07347002 Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing… Chikungunya Virus Infection Enrolling by Invitation 2026-07-17
NCT07163845 Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the… Chikungunya Virus Infection Active, Not Recruiting 2026-02-11
Get alerts when Valneva Austria GmbH's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free